Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yongbo Peng
PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Related publications
The PARP Inhibitor AZD2281 (Olaparib) Induces Autophagy/Mitophagy in BRCA1 and BRCA2 Mutant Breast Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α
British Journal of Cancer
Cancer Research
Oncology
RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance
Journal of Clinical Investigation
Medicine
HDAC Inhibitor SAHA Induces McPip1 Expression and Suppresses IL-6 Expression in Human OA Chondrocytes
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Current Problems in Cancer
Cancer Research
Oncology
Lysophosphatidic Acid Protects Cancer Cells From Histone Deacetylase (HDAC) Inhibitor-Induced Apoptosis Through Activation of HDAC
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
An HDAC Inhibitor Increases AcMNPV Gene Expression in Mammalian Cells
Archives of Virology
Medicine
Virology
The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair
Molecular Cancer Therapeutics
Cancer Research
Oncology
